Gut-Microbiota-Metabolite Axis in Early Renal Function Decline
- PMID: 26241311
- PMCID: PMC4524635
- DOI: 10.1371/journal.pone.0134311
Gut-Microbiota-Metabolite Axis in Early Renal Function Decline
Abstract
Introduction: Several circulating metabolites derived from bacterial protein fermentation have been found to be inversely associated with renal function but the timing and disease severity is unclear. The aim of this study is to explore the relationship between indoxyl-sulfate, p-cresyl-sulfate, phenylacetylglutamine and gut-microbial profiles in early renal function decline.
Results: Indoxyl-sulfate (Beta(SE) = -2.74(0.24); P = 8.8x10-29), p-cresyl-sulfate (-1.99(0.24), P = 4.6x10-16), and phenylacetylglutamine(-2.73 (0.25), P = 1.2x10-25) were inversely associated with eGFR in a large population base cohort (TwinsUK, n = 4439) with minimal renal function decline. In a sub-sample of 855 individuals, we analysed metabolite associations with 16S gut microbiome profiles (909 profiles, QIIME 1.7.0). Three Operational Taxonomic Units (OTUs) were significantly associated with indoxyl-sulfate and 52 with phenylacetylglutamine after multiple testing; while one OTU was nominally associated with p-cresyl sulfate. All 56 microbial members belong to the order Clostridiales and are represented by anaerobic Gram-positive families Christensenellaceae, Ruminococcaceae and Lachnospiraceae. Within these, three microbes were also associated with eGFR.
Conclusions: Our data suggest that indoxyl-sulfate, p-cresyl-sulfate and phenylacetylglutamine are early markers of renal function decline. Changes in the intestinal flora associated with these metabolites are detectable in early kidney disease. Future efforts should dissect this relationship to improve early diagnostics and therapeutics strategies.
Conflict of interest statement
Figures
Similar articles
-
In older women, a high-protein diet including animal-sourced foods did not impact serum levels and urinary excretion of trimethylamine-N-oxide.Nutr Res. 2020 Jun;78:72-81. doi: 10.1016/j.nutres.2020.05.004. Epub 2020 May 17. Nutr Res. 2020. PMID: 32544852 Clinical Trial.
-
Heritability and clinical determinants of serum indoxyl sulfate and p-cresyl sulfate, candidate biomarkers of the human microbiome enterotype.PLoS One. 2014 May 21;9(5):e79682. doi: 10.1371/journal.pone.0079682. eCollection 2014. PLoS One. 2014. PMID: 24850265 Free PMC article.
-
Synbiotics Easing Renal Failure by Improving Gut Microbiology (SYNERGY): A Randomized Trial.Clin J Am Soc Nephrol. 2016 Feb 5;11(2):223-31. doi: 10.2215/CJN.05240515. Epub 2016 Jan 15. Clin J Am Soc Nephrol. 2016. PMID: 26772193 Free PMC article. Clinical Trial.
-
Meta-Analysis of the Associations of p-Cresyl Sulfate (PCS) and Indoxyl Sulfate (IS) with Cardiovascular Events and All-Cause Mortality in Patients with Chronic Renal Failure.PLoS One. 2015 Jul 14;10(7):e0132589. doi: 10.1371/journal.pone.0132589. eCollection 2015. PLoS One. 2015. PMID: 26173073 Free PMC article. Review.
-
Indoxyl sulfate and p-cresyl sulfate in chronic kidney disease. Could these toxins modulate the antioxidant Nrf2-Keap1 pathway?J Ren Nutr. 2014 Sep;24(5):286-91. doi: 10.1053/j.jrn.2013.11.006. Epub 2014 Jan 28. J Ren Nutr. 2014. PMID: 24480117 Review.
Cited by
-
Exploration of Crucial Mediators for Carotid Atherosclerosis Pathogenesis Through Integration of Microbiome, Metabolome, and Transcriptome.Front Physiol. 2021 May 24;12:645212. doi: 10.3389/fphys.2021.645212. eCollection 2021. Front Physiol. 2021. PMID: 34108883 Free PMC article.
-
Modulation of the Gut Microbiota by Resistant Starch as a Treatment of Chronic Kidney Diseases: Evidence of Efficacy and Mechanistic Insights.Adv Nutr. 2019 Mar 1;10(2):303-320. doi: 10.1093/advances/nmy068. Adv Nutr. 2019. PMID: 30668615 Free PMC article. Review.
-
Microbiome function underpins the efficacy of a fiber-supplemented dietary intervention in dogs with chronic large bowel diarrhea.BMC Vet Res. 2022 Jun 24;18(1):245. doi: 10.1186/s12917-022-03315-3. BMC Vet Res. 2022. PMID: 35751094 Free PMC article.
-
Association of Sarcopenia and Gut Microbiota Composition in Older Patients with Advanced Chronic Kidney Disease, Investigation of the Interactions with Uremic Toxins, Inflammation and Oxidative Stress.Toxins (Basel). 2021 Jul 8;13(7):472. doi: 10.3390/toxins13070472. Toxins (Basel). 2021. PMID: 34357944 Free PMC article.
-
The role of the gastrointestinal tract and microbiota on uremic toxins and chronic kidney disease development.Clin Exp Nephrol. 2017 Feb;21(1):7-15. doi: 10.1007/s10157-016-1255-y. Epub 2016 Mar 10. Clin Exp Nephrol. 2017. PMID: 26965149 Review.
References
-
- Monleon D, Morales JM, Barrasa A, Lopez JA, Vazquez C, Celda B. Metabolite profiling of fecal water extracts from human colorectal cancer. NMR in biomedicine, 22: 342–348, 2009. - PubMed
-
- Qin N, Yang F, Li A, Prifti E, Chen Y, Shao L, et al. Alterations of the human gut microbiome in liver cirrhosis. Nature, 513: 59–64, 2014. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
